Literature DB >> 19014373

Phosphorylation of tau at Ser214 mediates its interaction with 14-3-3 protein: implications for the mechanism of tau aggregation.

Golam Sadik1, Toshihisa Tanaka, Kiyoko Kato, Hidenaga Yamamori, Begum Nurun Nessa, Takashi Morihara, Masatoshi Takeda.   

Abstract

The microtubule associated protein tau is a major component of neurofibrillary tangles in Alzheimer disease brain, however the neuropathological processes behind the formation of neurofibrillary tangles are still unclear. Previously, 14-3-3 proteins were reported to bind with tau. 14-3-3 Proteins usually bind their targets through specific serine/threonine -phosphorylated motifs. Therefore, the interaction of tau with 14-3-3 mediated by phosphorylation was investigated. In this study, we show that the phosphorylation of tau by either protein kinase A (PKA) or protein kinase B (PKB) enhances the binding of tau with 14-3-3 in vitro. The affinity between tau and 14-3-3 is increased 12- to 14-fold by phosphorylation as determined by real time surface plasmon resonance studies. Mutational analyses revealed that Ser214 is critical for the phosphorylation-mediated interaction of tau with 14-3-3. Finally, in vitro aggregation assays demonstrated that phosphorylation by PKA/PKB inhibits the formation of aggregates/filaments of tau induced by 14-3-3. As the phosphorylation at Ser214 is up-regulated in fetal brain, tau's interaction with 14-3-3 may have a significant role in the organization of the microtubule cytoskeleton in development. Also as the phosphorylation at Ser214 is up-regulated in Alzheimer's disease brain, tau's interaction with 14-3-3 might be involved in the pathology of this disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19014373     DOI: 10.1111/j.1471-4159.2008.05716.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  36 in total

1.  Tau-driven 26S proteasome impairment and cognitive dysfunction can be prevented early in disease by activating cAMP-PKA signaling.

Authors:  Natura Myeku; Catherine L Clelland; Sheina Emrani; Nikolay V Kukushkin; Wai Haung Yu; Alfred L Goldberg; Karen E Duff
Journal:  Nat Med       Date:  2015-12-21       Impact factor: 53.440

Review 2.  14-3-3/Tau Interaction and Tau Amyloidogenesis.

Authors:  Yuwen Chen; Xingyu Chen; Zhiyang Yao; Yuqi Shi; Junwen Xiong; Jingjing Zhou; Zhengding Su; Yongqi Huang
Journal:  J Mol Neurosci       Date:  2019-05-06       Impact factor: 3.444

3.  CNS cell type-specific gene profiling of P301S tau transgenic mice identifies genes dysregulated by progressive tau accumulation.

Authors:  Yazi D Ke; Gabriella Chan; Kristie Stefanoska; Carol Au; Mian Bi; Julius Müller; Magdalena Przybyla; Astrid Feiten; Emmanuel Prikas; Glenda M Halliday; Olivier Piguet; Matthew C Kiernan; Michael Kassiou; John R Hodges; Clement T Loy; John S Mattick; Arne Ittner; Jillian J Kril; Greg T Sutherland; Lars M Ittner
Journal:  J Biol Chem       Date:  2019-07-31       Impact factor: 5.157

4.  Proteasome inhibition-induced downregulation of Akt/GSK-3β pathway contributes to abnormality of tau in hippocampal slice.

Authors:  Min Xie; Ruihong Shi; Ying Pan; Tao Zeng; Qicai Chen; Shaohui Wang; Xiaomei Liao
Journal:  Mol Neurobiol       Date:  2014-04-22       Impact factor: 5.590

5.  The Involvement of NR2B and tau Protein in MG132-Induced CREB Dephosphorylation.

Authors:  Min Xie; Yuan Li; Shao-Hui Wang; Qun-Tao Yu; Xin Meng; Xiao-Mei Liao
Journal:  J Mol Neurosci       Date:  2017-04-19       Impact factor: 3.444

Review 6.  14-3-3 proteins as potential therapeutic targets.

Authors:  Jing Zhao; Cheryl L Meyerkord; Yuhong Du; Fadlo R Khuri; Haian Fu
Journal:  Semin Cell Dev Biol       Date:  2011-10-01       Impact factor: 7.727

7.  Parkinsonian neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) and alpha-synuclein mutations promote Tau protein phosphorylation at Ser262 and destabilize microtubule cytoskeleton in vitro.

Authors:  Hamid Y Qureshi; Hemant K Paudel
Journal:  J Biol Chem       Date:  2010-12-02       Impact factor: 5.157

Review 8.  Brain hypometabolism triggers PHF-like phosphorylation of tau, a major hallmark of Alzheimer's disease pathology.

Authors:  Thomas Arendt; Jens Stieler; Max Holzer
Journal:  J Neural Transm (Vienna)       Date:  2014-12-06       Impact factor: 3.575

Review 9.  Anesthesia and tau pathology.

Authors:  Robert A Whittington; Alexis Bretteville; Maya F Dickler; Emmanuel Planel
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2013-03-25       Impact factor: 5.067

Review 10.  Oxidatively modified proteins in Alzheimer's disease (AD), mild cognitive impairment and animal models of AD: role of Abeta in pathogenesis.

Authors:  Rukhsana Sultana; Marzia Perluigi; D Allan Butterfield
Journal:  Acta Neuropathol       Date:  2009-03-14       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.